Share Price and Basic Stock Data
Last Updated: October 29, 2025, 8:50 am
| PEG Ratio | 5.10 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
DMCC Speciality Chemicals Ltd operates in the specialty chemicals sector, focusing on niche markets that require tailored solutions. As of now, the company’s stock price stood at ₹314, with a market capitalization of ₹785 Cr. Over the years, DMCC has demonstrated an impressive growth trajectory, with annual sales rising from ₹101 Cr in March 2014 to ₹431 Cr in March 2025. The trailing twelve months (TTM) revenue reached ₹473 Cr, indicating a robust demand for its products. Quarterly sales figures displayed volatility, with the highest quarterly revenue recorded at ₹113.39 Cr in June 2022 and a recent decline to ₹76.52 Cr in September 2023, highlighting the seasonal nature of its business. However, a notable uptrend is visible in the latest quarters, suggesting a potential recovery as sales increased to ₹85.57 Cr in June 2023 and ₹80.53 Cr in December 2023. This growth reflects both market resilience and strategic management in navigating challenges within the specialty chemicals landscape.
Profitability and Efficiency Metrics
DMCC’s profitability metrics reveal a mixed performance, with operating profit margins (OPM) fluctuating significantly. The OPM stood at 13.29% in the most recent reporting period, reflecting a recovery from a low of 1.50% in December 2022. The company reported an operating profit of ₹57 Cr for the fiscal year ending March 2025, up from ₹36 Cr in March 2024. Notably, the net profit margin improved to 4.99% in March 2025, compared to 1.80% in March 2023, showcasing effective cost management. The interest coverage ratio (ICR) of 5.56x indicates that DMCC is well-positioned to meet its interest obligations, with interest expenses recorded at ₹10 Cr for the year. Return on equity (ROE) stood at 9.97%, while return on capital employed (ROCE) was reported at 14.1%, both of which are reasonable figures in comparison to sector averages. However, the company should focus on enhancing its operational efficiency to sustain profitability amidst fluctuating raw material prices and market conditions.
Balance Sheet Strength and Financial Ratios
DMCC’s balance sheet reflects a stable financial position with total assets of ₹380 Cr as of March 2025. The company reported reserves of ₹202 Cr, which is a significant increase from ₹173 Cr in March 2023, underscoring its capacity to reinvest in growth initiatives. Borrowings were recorded at ₹72 Cr, resulting in a manageable debt-to-equity ratio of 0.20, indicating prudent financial leverage. The current ratio stood at 1.23, suggesting adequate liquidity to meet short-term obligations. Furthermore, the price-to-book value ratio (P/BV) was reported at 3.29x, reflecting investor confidence but also indicating that the stock may be trading at a premium compared to its net asset value. The company’s asset turnover ratio increased to 1.14, highlighting improved efficiency in utilizing its assets to generate revenue. However, the cash conversion cycle of 37 days suggests that there is room for improvement in managing working capital effectively.
Shareholding Pattern and Investor Confidence
Investor confidence in DMCC is evidenced by its shareholding pattern, where promoters hold a substantial 53.84% stake, reflecting strong insider commitment. The public holds 43.68% of the shares, while foreign institutional investors (FIIs) have increased their stake from a mere 0.05% in March 2023 to 1.16% by June 2025, demonstrating growing interest from international investors. Domestic institutional investors (DIIs) have maintained a steady stake of around 1.31%. The number of shareholders has also seen fluctuations, with 22,128 shareholders recorded in June 2025. This steady participation from various investor categories indicates a diversified investor base, which is generally favorable for stock stability. However, the relatively low foreign institutional investment compared to sector peers may raise questions about the company’s global competitiveness. DMCC should focus on enhancing its visibility and attractiveness to foreign investors to further strengthen its market position.
Outlook, Risks, and Final Insight
Looking ahead, DMCC Speciality Chemicals Ltd has several strengths, including a solid financial foundation, a robust growth trajectory in sales, and a committed promoter group. However, the company faces risks such as fluctuating raw material costs, potential disruptions in global supply chains, and the inherent volatility of the specialty chemicals market. The recent increase in sales and profitability metrics provides a positive outlook, but sustained performance will depend on effective management of operational efficiencies and market dynamics. Should demand for specialty chemicals continue to grow, supported by trends in sustainable and specialty applications, DMCC could capitalize on these opportunities. Conversely, failure to address operational challenges or adverse economic conditions may hinder growth. Overall, DMCC’s strategic initiatives and market positioning will be crucial in navigating these dynamics and achieving long-term success in the competitive specialty chemicals landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of DMCC Speciality Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 423 Cr. | 46.3 | 88.0/42.6 | 25.8 | 20.0 | 0.86 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 38.2 Cr. | 77.9 | 104/56.0 | 17.1 | 87.4 | 1.28 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.2 Cr. | 724 | 1,178/600 | 53.5 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,811 Cr. | 84.0 | 114/78.0 | 25.4 | 20.7 | 0.59 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 783 Cr. | 314 | 453/241 | 28.1 | 91.1 | 0.80 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 13,019.88 Cr | 763.34 | 47.96 | 178.12 | 0.41% | 12.99% | 25.41% | 6.44 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 113.39 | 104.71 | 71.91 | 96.50 | 85.57 | 76.52 | 80.53 | 83.95 | 85.32 | 102.70 | 118.03 | 125.19 | 127.02 |
| Expenses | 98.49 | 101.11 | 70.83 | 80.21 | 74.60 | 66.99 | 73.41 | 76.55 | 76.47 | 87.40 | 100.29 | 110.07 | 110.14 |
| Operating Profit | 14.90 | 3.60 | 1.08 | 16.29 | 10.97 | 9.53 | 7.12 | 7.40 | 8.85 | 15.30 | 17.74 | 15.12 | 16.88 |
| OPM % | 13.14% | 3.44% | 1.50% | 16.88% | 12.82% | 12.45% | 8.84% | 8.81% | 10.37% | 14.90% | 15.03% | 12.08% | 13.29% |
| Other Income | 0.72 | 0.40 | 0.91 | 0.77 | 0.88 | 0.81 | 0.67 | 9.29 | 0.21 | 0.31 | 0.39 | 0.44 | 0.37 |
| Interest | 2.29 | 1.84 | 3.16 | 3.29 | 3.47 | 2.88 | 3.56 | 3.85 | 3.01 | 2.77 | 2.53 | 2.19 | 2.03 |
| Depreciation | 3.32 | 4.92 | 4.80 | 4.54 | 3.55 | 3.90 | 3.91 | 4.33 | 4.16 | 4.25 | 4.25 | 4.03 | 4.19 |
| Profit before tax | 10.01 | -2.76 | -5.97 | 9.23 | 4.83 | 3.56 | 0.32 | 8.51 | 1.89 | 8.59 | 11.35 | 9.34 | 11.03 |
| Tax % | 37.96% | 0.00% | -45.23% | 27.63% | 34.99% | 33.71% | 6.25% | 32.20% | 26.46% | 32.36% | 30.57% | 30.73% | 29.74% |
| Net Profit | 6.22 | -2.77 | -3.28 | 6.68 | 3.14 | 2.36 | 0.29 | 5.78 | 1.39 | 5.80 | 7.88 | 6.47 | 7.75 |
| EPS in Rs | 2.49 | -1.11 | -1.32 | 2.68 | 1.26 | 0.95 | 0.12 | 2.32 | 0.56 | 2.33 | 3.16 | 2.59 | 3.11 |
Last Updated: August 19, 2025, 7:55 pm
Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 127.02 Cr.. The value appears strong and on an upward trend. It has increased from 125.19 Cr. (Mar 2025) to 127.02 Cr., marking an increase of 1.83 Cr..
- For Expenses, as of Jun 2025, the value is 110.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.07 Cr. (Mar 2025) to 110.14 Cr., marking an increase of 0.07 Cr..
- For Operating Profit, as of Jun 2025, the value is 16.88 Cr.. The value appears strong and on an upward trend. It has increased from 15.12 Cr. (Mar 2025) to 16.88 Cr., marking an increase of 1.76 Cr..
- For OPM %, as of Jun 2025, the value is 13.29%. The value appears strong and on an upward trend. It has increased from 12.08% (Mar 2025) to 13.29%, marking an increase of 1.21%.
- For Other Income, as of Jun 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Mar 2025) to 0.37 Cr., marking a decrease of 0.07 Cr..
- For Interest, as of Jun 2025, the value is 2.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.19 Cr. (Mar 2025) to 2.03 Cr., marking a decrease of 0.16 Cr..
- For Depreciation, as of Jun 2025, the value is 4.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.03 Cr. (Mar 2025) to 4.19 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Jun 2025, the value is 11.03 Cr.. The value appears strong and on an upward trend. It has increased from 9.34 Cr. (Mar 2025) to 11.03 Cr., marking an increase of 1.69 Cr..
- For Tax %, as of Jun 2025, the value is 29.74%. The value appears to be improving (decreasing) as expected. It has decreased from 30.73% (Mar 2025) to 29.74%, marking a decrease of 0.99%.
- For Net Profit, as of Jun 2025, the value is 7.75 Cr.. The value appears strong and on an upward trend. It has increased from 6.47 Cr. (Mar 2025) to 7.75 Cr., marking an increase of 1.28 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.11. The value appears strong and on an upward trend. It has increased from 2.59 (Mar 2025) to 3.11, marking an increase of 0.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 120 | 108 | 175 | 178 | 227 | 188 | 200 | 326 | 387 | 328 | 431 | 473 |
| Expenses | 86 | 101 | 91 | 145 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 408 |
| Operating Profit | 15 | 20 | 16 | 30 | 23 | 53 | 28 | 36 | 41 | 36 | 36 | 57 | 65 |
| OPM % | 15% | 16% | 15% | 17% | 13% | 24% | 15% | 18% | 12% | 9% | 11% | 13% | 14% |
| Other Income | 6 | -1 | 0 | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 2 |
| Interest | 2 | 2 | 1 | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 10 | 10 |
| Depreciation | 3 | 2 | 2 | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 17 |
| Profit before tax | 16 | 14 | 13 | 21 | 16 | 47 | 26 | 34 | 34 | 10 | 17 | 31 | 40 |
| Tax % | 0% | 0% | 9% | 21% | 21% | 2% | -22% | 4% | 37% | 35% | 33% | 31% | |
| Net Profit | 16 | 14 | 12 | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 28 |
| EPS in Rs | 7.55 | 6.58 | 5.63 | 7.79 | 4.92 | 18.47 | 12.63 | 13.06 | 8.56 | 2.75 | 4.64 | 8.64 | 11.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 10% | 8% | 0% | 15% | 6% | 0% | 22% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.50% | -14.29% | 41.67% | -29.41% | 283.33% | -32.61% | 6.45% | -36.36% | -66.67% | 71.43% | 83.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.79% | 55.95% | -71.08% | 312.75% | -315.94% | 39.06% | -42.82% | -30.30% | 138.10% | 11.90% |
DMCC Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 10% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -7% |
| 3 Years: | 1% |
| TTM: | 184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | -8% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: September 10, 2025, 3:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -13 | 1 | 13 | 35 | 48 | 91 | 120 | 148 | 168 | 173 | 184 | 202 |
| Borrowings | 38 | 35 | 27 | 30 | 25 | 22 | 25 | 35 | 93 | 101 | 88 | 72 |
| Other Liabilities | 53 | 32 | 34 | 59 | 59 | 51 | 42 | 55 | 97 | 101 | 80 | 81 |
| Total Liabilities | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 |
| Fixed Assets | 26 | 24 | 26 | 83 | 87 | 99 | 101 | 108 | 174 | 230 | 238 | 234 |
| CWIP | 1 | 1 | 5 | 3 | 3 | 1 | 9 | 38 | 63 | 11 | 6 | 0 |
| Investments | 0 | 0 | 0 | 2 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 72 | 63 | 63 | 60 | 62 | 86 | 98 | 116 | 146 | 159 | 132 | 145 |
| Total Assets | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 |
Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Mar 2025, the value is 202.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Mar 2024) to 202.00 Cr., marking an increase of 18.00 Cr..
- For Borrowings, as of Mar 2025, the value is 72.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 88.00 Cr. (Mar 2024) to 72.00 Cr., marking a decrease of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 234.00 Cr.. The value appears to be declining and may need further review. It has decreased from 238.00 Cr. (Mar 2024) to 234.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 6.00 Cr..
- For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Mar 2024) to 145.00 Cr., marking an increase of 13.00 Cr..
- For Total Assets, as of Mar 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (202.00 Cr.) exceed the Borrowings (72.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -23.00 | -15.00 | -11.00 | 0.00 | -2.00 | 31.00 | 3.00 | 1.00 | -52.00 | -65.00 | -52.00 | -15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 44 | 44 | 45 | 45 | 48 | 48 | 58 | 56 | 49 | 51 | 63 |
| Inventory Days | 52 | 62 | 104 | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 |
| Days Payable | 126 | 76 | 115 | 129 | 114 | 79 | 68 | 116 | 131 | 121 | 119 | 84 |
| Cash Conversion Cycle | -12 | 29 | 33 | -25 | 4 | 49 | 93 | 94 | 3 | 6 | 13 | 37 |
| Working Capital Days | 15 | 1 | -7 | -37 | -6 | 43 | 80 | 32 | -5 | 2 | 5 | 16 |
| ROCE % | 34% | 34% | 24% | 35% | 21% | 43% | 18% | 19% | 16% | 7% | 8% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Diluted EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Cash EPS (Rs.) | 15.34 | 10.95 | 9.84 | 11.79 | 15.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Revenue From Operations / Share (Rs.) | 172.93 | 131.50 | 154.26 | 130.83 | 80.25 |
| PBDIT / Share (Rs.) | 23.40 | 18.73 | 15.55 | 18.48 | 17.35 |
| PBIT / Share (Rs.) | 16.70 | 12.43 | 8.49 | 15.25 | 14.61 |
| PBT / Share (Rs.) | 12.48 | 6.92 | 4.25 | 13.69 | 13.65 |
| Net Profit / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| NP After MI And SOA / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| PBDIT Margin (%) | 13.53 | 14.24 | 10.07 | 14.12 | 21.61 |
| PBIT Margin (%) | 9.65 | 9.45 | 5.50 | 11.65 | 18.20 |
| PBT Margin (%) | 7.21 | 5.26 | 2.75 | 10.46 | 17.00 |
| Net Profit Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| NP After MI And SOA Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| Return on Networth / Equity (%) | 9.45 | 5.53 | 3.49 | 11.02 | 18.81 |
| Return on Capital Employeed (%) | 15.38 | 11.47 | 7.88 | 15.10 | 18.68 |
| Return On Assets (%) | 5.66 | 3.07 | 1.72 | 5.56 | 12.35 |
| Long Term Debt / Equity (X) | 0.17 | 0.27 | 0.34 | 0.28 | 0.09 |
| Total Debt / Equity (X) | 0.20 | 0.31 | 0.40 | 0.40 | 0.14 |
| Asset Turnover Ratio (%) | 1.14 | 0.84 | 0.98 | 1.01 | 0.84 |
| Current Ratio (X) | 1.23 | 1.08 | 1.04 | 0.95 | 1.68 |
| Quick Ratio (X) | 0.84 | 0.66 | 0.63 | 0.64 | 1.13 |
| Inventory Turnover Ratio (X) | 9.95 | 4.03 | 5.48 | 5.09 | 2.94 |
| Dividend Payout Ratio (NP) (%) | 11.58 | 0.00 | 35.98 | 5.84 | 11.68 |
| Dividend Payout Ratio (CP) (%) | 6.52 | 0.00 | 10.16 | 4.24 | 9.65 |
| Earning Retention Ratio (%) | 88.42 | 0.00 | 64.02 | 94.16 | 88.32 |
| Cash Earning Retention Ratio (%) | 93.48 | 0.00 | 89.84 | 95.76 | 90.35 |
| Interest Coverage Ratio (X) | 5.56 | 3.40 | 3.67 | 11.84 | 18.03 |
| Interest Coverage Ratio (Post Tax) (X) | 3.05 | 1.84 | 1.66 | 6.48 | 14.57 |
| Enterprise Value (Cr.) | 789.57 | 745.75 | 677.05 | 982.66 | 815.55 |
| EV / Net Operating Revenue (X) | 1.83 | 2.27 | 1.76 | 3.01 | 4.07 |
| EV / EBITDA (X) | 13.53 | 15.96 | 17.46 | 21.32 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| Retention Ratios (%) | 88.41 | 0.00 | 64.01 | 94.15 | 88.31 |
| Price / BV (X) | 3.29 | 3.27 | 3.02 | 4.69 | 4.58 |
| Price / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
- For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
- For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 8. It has increased from 4.03 (Mar 24) to 9.95, marking an increase of 5.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.58. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 11.58, marking an increase of 11.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.52. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.52, marking an increase of 6.52.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.42, marking an increase of 88.42.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.48. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.48, marking an increase of 93.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 88.41. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.41, marking an increase of 88.41.
- For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DMCC Speciality Chemicals Ltd:
- Net Profit Margin: 4.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.38% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.45% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.84
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.1 (Industry average Stock P/E: 47.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Prospect Chambers, 317/321, Dr. Dadabhoy Naoroji Road, Mumbai Maharashtra 400001 | investors@dmcc.com http://www.dmcc.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Laxmikumar Narottam Goculdas | Chairman |
| Ms. Mitika Laxmikumar Goculdas | Vice Chairperson |
| Mr. Bimal Lalitsingh Goculdas | Managing Director & CEO |
| Mr. Kuldeep Kumar Tiwari | Executive Director - Operations |
| Mr. Mukul Manoharlal Taly | Ind. Non-Executive Director |
| Mr. Sanjeev Vishwanath Joshi | Ind. Non-Executive Director |
| Dr.(Mrs.) Janaki Ashwin Patwardhan | Ind. Non-Executive Director |
| Mr. Haren Devidas Parekh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of DMCC Speciality Chemicals Ltd?
DMCC Speciality Chemicals Ltd's intrinsic value (as of 29 October 2025) is 205.81 which is 34.46% lower the current market price of 314.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 783 Cr. market cap, FY2025-2026 high/low of 453/241, reserves of ₹202 Cr, and liabilities of 380 Cr.
What is the Market Cap of DMCC Speciality Chemicals Ltd?
The Market Cap of DMCC Speciality Chemicals Ltd is 783 Cr..
What is the current Stock Price of DMCC Speciality Chemicals Ltd as on 29 October 2025?
The current stock price of DMCC Speciality Chemicals Ltd as on 29 October 2025 is 314.
What is the High / Low of DMCC Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DMCC Speciality Chemicals Ltd stocks is 453/241.
What is the Stock P/E of DMCC Speciality Chemicals Ltd?
The Stock P/E of DMCC Speciality Chemicals Ltd is 28.1.
What is the Book Value of DMCC Speciality Chemicals Ltd?
The Book Value of DMCC Speciality Chemicals Ltd is 91.1.
What is the Dividend Yield of DMCC Speciality Chemicals Ltd?
The Dividend Yield of DMCC Speciality Chemicals Ltd is 0.80 %.
What is the ROCE of DMCC Speciality Chemicals Ltd?
The ROCE of DMCC Speciality Chemicals Ltd is 14.1 %.
What is the ROE of DMCC Speciality Chemicals Ltd?
The ROE of DMCC Speciality Chemicals Ltd is 9.97 %.
What is the Face Value of DMCC Speciality Chemicals Ltd?
The Face Value of DMCC Speciality Chemicals Ltd is 10.0.